Article Text

Download PDFPDF
16 Extended vte prophylaxis for all – ensuring correct prescirption after major gi oncological resection
  1. D Spence1,
  2. J Devlin1,
  3. L McKie2,
  4. R Kennedy2,
  5. T McAdam2
  1. 1Core Surgical Trainee 2, Belfast Health and Social Care Trust, UK
  2. 2Consultant Surgeon, Belfast Health and Social Care Trust, UK

Abstract

Using a single audit process across the 3 General Surgical Units in the Belfast Trust, Northern Ireland, we identified a lack of adequate extended post-op venous-thromboembolism prophylaxis (EVTEP) in patients following major resection for GI malignancies (as recommended by NICE: CG 92 and endorsed by the 3 UK General Surgical Associations – AUGIS, ACPGBI, and GBIHPBA).

We identified 2 areas that we felt, with intervention, could bring departmental performance into sync with national recommendations.

  1. Lack of knowledge amongst FY1 Doctors of the need for EVTEP.

  2. Lack of a Trust-wide policy on EVTEP.

Our planned interventions included;

  1. 1. Creation of a Trust-wide policy.

  2. 2. Delivery of a presentation on EVTEP for junior doctors during departmental induction at each 4 or 6 month rotation.

  3. 3. Creation of an electronic fail-safe on the existing electronic discharge letters preventing letter/script being cleared for sending to pharmacy unless EVTEP was addressed.

Improvement was to be measured in the form of a re-audit over a further 6 month period once all the suggested changes had been implemented.

Due to the length of time it has taken interventions 1 and 3 to be implemented (greater than 1 year) – it has not been feasible to complete the full re-audit of the impact of all three interventions prior to the date of the conference in Liverpool.

In the interim we are collecting re-audit data to measure improvement secondary to intervention number 2 which has been rolled out since our original findings in 2016. This data will be collected from the 2 funded units involved as one currently does not have funding allocated for EVTEP.

The results from the mini-re-audit will be available for presentation by October 2017 and we anticipate that we will be able to demonstrate an improvement in overall prescription of EVTEP following full re-audit of our interventions.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.